178 related articles for article (PubMed ID: 36845160)
1. Screening and epitope characterization of diagnostic nanobody against total and activated
Guo Y; Ouyang Z; He W; Zhang J; Qin Q; Jiao M; Muyldermans S; Zheng F; Wen Y
Front Immunol; 2023; 14():1065274. PubMed ID: 36845160
[TBL] [Abstract][Full Text] [Related]
2. Enterotoxigenic
Zamani S; Taslimi R; Sarabi A; Jasemi S; Sechi LA; Feizabadi MM
Front Cell Infect Microbiol; 2019; 9():449. PubMed ID: 32010637
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies specific for Bacteroides fragilis enterotoxins BFT1 and BFT2 and their use in immunoassays.
Mootien S; Kaplan PM
PLoS One; 2017; 12(3):e0173128. PubMed ID: 28257448
[TBL] [Abstract][Full Text] [Related]
4. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes.
Sears CL
Clin Microbiol Rev; 2009 Apr; 22(2):349-69, Table of Contents. PubMed ID: 19366918
[TBL] [Abstract][Full Text] [Related]
5. Comparison of microbiological profile of enterotoxigenic Bacteroides fragilis (ETBF) isolates from subjects with colorectal cancer (CRC) or intestinal pre-cancerous lesions versus healthy individuals and evaluation of environmental factors involved in intestinal dysbiosis.
Spigaglia P; Barbanti F; Germinario EAP; Criscuolo EM; Bruno G; Sanchez-Mete L; Porowska B; Stigliano V; Accarpio F; Oddi A; Zingale I; Rossi S; De Angelis R; Fabbri A
Anaerobe; 2023 Aug; 82():102757. PubMed ID: 37380012
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pathogenicity of the Bacteroides fragilis toxin gene subtypes in gnotobiotic mice.
Nakano V; Gomes DA; Arantes RM; Nicoli JR; Avila-Campos MJ
Curr Microbiol; 2006 Aug; 53(2):113-7. PubMed ID: 16832728
[TBL] [Abstract][Full Text] [Related]
7. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.
Rhee KJ; Wu S; Wu X; Huso DL; Karim B; Franco AA; Rabizadeh S; Golub JE; Mathews LE; Shin J; Sartor RB; Golenbock D; Hamad AR; Gan CM; Housseau F; Sears CL
Infect Immun; 2009 Apr; 77(4):1708-18. PubMed ID: 19188353
[TBL] [Abstract][Full Text] [Related]
8. Entero-toxigenic
Yang J; Wang X; Hu T; Huang H; Chen G; Jin B; Zeng G; Liu J
Cell Cycle; 2024 Jan; 23(1):70-82. PubMed ID: 38273425
[TBL] [Abstract][Full Text] [Related]
9. Repositioning small molecule drugs as allosteric inhibitors of the BFT-3 toxin from enterotoxigenic Bacteroides fragilis.
Jimenez-Alesanco A; Eckhard U; Asencio Del Rio M; Vega S; Guevara T; Velazquez-Campoy A; Gomis-Rüth FX; Abian O
Protein Sci; 2022 Oct; 31(10):e4427. PubMed ID: 36173175
[TBL] [Abstract][Full Text] [Related]
10. Fecal detection of enterotoxigenic Bacteroides fragilis.
Chen LA; Van Meerbeke S; Albesiano E; Goodwin A; Wu S; Yu H; Carroll K; Sears C
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1871-7. PubMed ID: 26173688
[TBL] [Abstract][Full Text] [Related]
11. Identification of a third metalloprotease toxin gene in extraintestinal isolates of Bacteroides fragilis.
Chung GT; Franco AA; Wu S; Rhie GE; Cheng R; Oh HB; Sears CL
Infect Immun; 1999 Sep; 67(9):4945-9. PubMed ID: 10456956
[TBL] [Abstract][Full Text] [Related]
12. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.
Boleij A; Hechenbleikner EM; Goodwin AC; Badani R; Stein EM; Lazarev MG; Ellis B; Carroll KC; Albesiano E; Wick EC; Platz EA; Pardoll DM; Sears CL
Clin Infect Dis; 2015 Jan; 60(2):208-15. PubMed ID: 25305284
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene.
Franco AA; Mundy LM; Trucksis M; Wu S; Kaper JB; Sears CL
Infect Immun; 1997 Mar; 65(3):1007-13. PubMed ID: 9038310
[TBL] [Abstract][Full Text] [Related]
14. The toxins of Bacteroides fragilis.
Sears CL
Toxicon; 2001 Nov; 39(11):1737-46. PubMed ID: 11595636
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and analysis of rare cfiA-bft doubly positive Bacteroides fragilis strains.
Sóki J; Eitel Z; Terhes G; Nagy E; Urbán E;
Anaerobe; 2013 Oct; 23():70-3. PubMed ID: 23796697
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prevalence of enterotoxigenic Bacteroides fragilis and the distribution bft gene subtypes in patients with diarrhea.
Akpınar M; Aktaş E; Cömert F; Külah C; Sümbüloğlu V
Anaerobe; 2010 Oct; 16(5):505-9. PubMed ID: 20709181
[TBL] [Abstract][Full Text] [Related]
17. [Enterotoxigenic Bacteroides fragilis as a factor in diarrhea].
Durmaz B
Mikrobiyol Bul; 2002 Jan; 36(1):99-103. PubMed ID: 12476774
[TBL] [Abstract][Full Text] [Related]
18. Screening for enterotoxigenic Bacteroides fragilis in stool samples.
Keenan JI; Aitchison A; Purcell RV; Greenlees R; Pearson JF; Frizelle FA
Anaerobe; 2016 Aug; 40():50-3. PubMed ID: 27166180
[TBL] [Abstract][Full Text] [Related]
19. The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F; Goli E; Mirzaei B; Zeighami H
BMC Cancer; 2019 Sep; 19(1):879. PubMed ID: 31488085
[TBL] [Abstract][Full Text] [Related]
20. A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan.
Kato N; Liu CX; Kato H; Watanabe K; Tanaka Y; Yamamoto T; Suzuki K; Ueno K
FEMS Microbiol Lett; 2000 Jan; 182(1):171-6. PubMed ID: 10612750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
